Medline Namic Angiographic Manifold Recall Issued

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries, LP is recalling 38,175 units of Namic Angiographic Manifolds due to particulate in the fluid path.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on June 3, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

Medline Industries, LP has initiated a recall of certain Namic Angiographic Manifolds after identifying the presence of particulate within the fluid path.

Which Products Are Affected

The recall covers Namic Angiographic Manifold, custom, Medline Product Number/SKU 64038301 (also described as Cardiopulmonary bypass adaptor, stopcock, manifold, or fitting). A total of 38,175 units are affected. Affected lot numbers include: 89631, 92244, 92464, 93148, 94033, 94851, 101093, 101989, 103550, 109976, 112236, 112333, 114288, 115691, 121707, 126993, 137933, 142147, 162786, 191812. UDI/DI: each 10193489059168, case 30193489059162. The recall number is Z-2139-2026. Distribution was nationwide in the US and to AE, AU, CA, JP, KR, NL, SG, SK.

What You Should Do

Consumers and facilities should follow instructions provided by Medline Industries, LP regarding the recalled products.

Why This Matters

This Class I recall involves devices distributed across the United States and internationally.

Source

FDA recall Z-2139-2026, Medline Industries, LP, Northfield, IL.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries, LP is recalling 38,175 units of Namic Angiographic Manifolds due to particulate in the fluid path.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "high" severity. Take precautions and monitor for updates.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.